Asymchem Laboratories Tian Jin Co Ltd
Asymchem Laboratories (Tianjin) Co., Ltd. provides clinical stage CDMO, commercial stage CDMO, and emerging services in Mainland China and internationally. The company offers API solutions, such as small molecules, highly potent, carbapenems, glycans, peptides, oligonucleotides, and therapeutic enzymes; GMP, non-GMP, asymchem lab facilities and capabilities, commercial manufacturing, clinical man… Read more
Asymchem Laboratories Tian Jin Co Ltd (002821) - Total Liabilities
Latest total liabilities as of September 2025: CN¥2.45 Billion CNY
Based on the latest financial reports, Asymchem Laboratories Tian Jin Co Ltd (002821) has total liabilities worth CN¥2.45 Billion CNY as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Asymchem Laboratories Tian Jin Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Asymchem Laboratories Tian Jin Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Asymchem Laboratories Tian Jin Co Ltd Competitors by Total Liabilities
The table below lists competitors of Asymchem Laboratories Tian Jin Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Redwood Trust, Inc.
NYSE:RWTP
|
USA | $22.72 Billion |
|
Q2 Holdings
NYSE:QTWO
|
USA | $614.47 Million |
|
SoundHound AI Inc
NASDAQ:SOUN
|
USA | $224.39 Million |
|
Neway Valve suzhou Co Ltd
SHG:603699
|
China | CN¥5.93 Billion |
|
WD-40 Company
NASDAQ:WDFC
|
USA | $195.60 Million |
|
Thunder Software Technology Co Ltd
SHE:300496
|
China | CN¥2.78 Billion |
|
Far Eastern New Century Corp
TW:1402
|
Taiwan | NT$359.56 Billion |
|
Alm. Brand A/S
PINK:ABDBY
|
USA | $20.05 Billion |
Liability Composition Analysis (2011–2024)
This chart breaks down Asymchem Laboratories Tian Jin Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 6.37 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.14 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.12 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Asymchem Laboratories Tian Jin Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Asymchem Laboratories Tian Jin Co Ltd (2011–2024)
The table below shows the annual total liabilities of Asymchem Laboratories Tian Jin Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥2.43 Billion | +7.48% |
| 2023-12-31 | CN¥2.26 Billion | -11.28% |
| 2022-12-31 | CN¥2.54 Billion | -0.08% |
| 2021-12-31 | CN¥2.55 Billion | +118.94% |
| 2020-12-31 | CN¥1.16 Billion | +63.06% |
| 2019-12-31 | CN¥713.23 Million | +5.70% |
| 2018-12-31 | CN¥674.77 Million | +39.95% |
| 2017-12-31 | CN¥482.17 Million | -21.20% |
| 2016-12-31 | CN¥611.91 Million | +82.94% |
| 2015-12-31 | CN¥334.48 Million | +22.52% |
| 2014-12-31 | CN¥273.00 Million | +20.22% |
| 2013-12-31 | CN¥227.09 Million | +3.25% |
| 2012-12-31 | CN¥219.94 Million | -14.80% |
| 2011-12-31 | CN¥258.15 Million | -- |